
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global non-invasive glucose monitoring market was valued at USD 182.10 Million in 2024 driven by the rising prevalence of diabetes across the globe. The market is anticipated to grow at a CAGR of 8.30% during the forecast period of 2025-2034 to reach a value of USD 404.20 Million by 2034.
Base Year
Historical Year
Forecast Year
The market growth is driven by the rising prevalence of diabetes and obesity.
The market is experiencing new product launches with advanced features, poised to improve patient outcomes in the coming years.
North America is expected to lead the market share based on region, which can be attributed to a well-developed infrastructure and a higher diabetes prevalence.
Value in USD Million
2025-2034
Non-Invasive Glucose Monitoring Market Outlook
*this image is indicative*
Blood sugar monitoring is used to manage diabetes in patients with concerning blood sugar levels also known as hypoglycemia and hyperglycemia. Commonly used blood sugar monitoring devices include glucometers in which needles are used to prick the fingers of diabetic patients to draw blood samples. The non-invasive glucose monitoring devices have been witnessing high demand in the market as the traditional method leaves the patient’s health compromised with chances of infections. This painful procedure and the emphasis on preventing the chance of infection have been triggering the need for new developments in the domain.
Rising Prevalence of Diabetes Boosts Market Growth
The market growth can be attributed to the rising prevalence of diabetes across the globe. The growing geriatric population which is prone to the disease is further impacting the market value positively. According to the International Diabetes Federation, 537 million people around the world are living with diabetes. It was responsible for 6.7 million deaths in 2021. The IDF further highlighted that diabetes caused a whopping USD 966 billion worth of health expenditure globally. This is a 316% increase in comparison to the last 15 years.
New Product Launches to Meet Rising Non-Invasive Glucose Monitoring Market Demand
In January 2024, Samsung revealed its plan to add non-invasive blood sugar monitoring to its consumer health devices portfolio. As the trend around digitally advanced wearable healthcare devices is rising, market players are putting more effort into developing the latest and more powerful wearable devices. Hence, non-invasive glucose monitoring devices are expected to be more comfortable and accurate, boosting market growth in the forecast period.
Increasing Clinical Studies and Research Activities
The market growth is driven by rising clinical studies and trials. For instance, in March 2024, Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, announced interim results from its most recent clinical research study. The study analysed the accuracy of Know Labs’ proprietary radiofrequency (RF) dielectric sensor in non-invasively measuring blood glucose in participants with prediabetes and Type 2 diabetes using venous blood as a comparative reference – resulting in an overall Mean Absolute Relative Difference (MARD) of 11.1%. The level of accuracy achieved by the radiofrequency (RF) dielectric sensor in measuring blood glucose non-invasively represents the rising adoption of such technologies in the coming years.
Moreover, in February 2024, Know Labs launched its KnowU device, a wearable, non-invasive continuous glucose monitor (CGM). The device is equipped with onboard computing power and machine learning capabilities in the presence of a unique and compact sensor that measures glucose levels via means of spectroscopy. Devices like knowU are also expected to be more cost-effective comparatively, thus propelling market growth.
The market is witnessing several trends and developments to improve the global current scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Increased Awareness and Diagnosis | There has been growing awareness about diabetes and the availability of non-invasive glucose monitoring devices. The benefits of using such devices and higher accuracy rates are gaining traction among healthcare providers and patients, propelling market demand. |
Increasing Research and Development Initiatives | The increasing efforts by researchers to remove the painless approach for blood sugar monitoring is one of the major trends. For instance, in March 2024, the Australian Research Council Center of Excellence for Transformative Meta-Optical Systems researched and found new aspects of the infrared signature of glucose and further used the information to develop a miniaturised optical sensor that was 5mm in diameter that could potentially provide continuous non-invasive glucose monitoring in diabetes management soon. |
Rising Adoption of Wearable Technology | The market is experiencing increasing innovations such as integration of glucose monitoring features in smart wearable devices like smartwatches, fitness trackers, and other wearable devices. The built-in feature in mobile apps offers continuous glucose monitoring (CGM) without performing invasive procedures. |
Heavy Investments Sponsoring Market Development | As the diabetes prevalence increases there is a significant rise in demand for non-invasive glucose monitoring devices for people living with diabetes and pre-diabetes. The market players are investing heavily in the development of such devices. For instance, in April 2024, BOYDSense, a medical device company which is developing a platform enabling simple and pain-free health monitoring, announced the completion of a EUR 7-million capital increase. |
Market Breakup by Product Type:
Market Breakup by Site Outlook:
Market Breakup by Application:
Market Breakup by End User:
Market Breakup by Region:
Segmentation by Application Dominating the Market Share
The market segmentation based on application includes intensive insulin therapy, hypoglycemia, diabetic foot ulcer tracking, and others. The market share is led by intensive insulin therapy due to the increasing prevalence of diabetes requiring constant monitoring and precise insulin management. Additionally, the trend toward personalised medicine further fuels the demand for non-invasive solutions that can provide continuous and reliable data, propelling market share growth.
North America leads the non-invasive glucose monitoring regional market due to the high prevalence of diabetes in the region. There is a substantial demand for innovative monitoring solutions, including non-invasive options. The regional dominance can be attributed to the presence of many leading medical device companies and research institutions, which are at the forefront of developing and commercialising advanced non-invasive glucose monitoring technologies.
The region has a robust healthcare infrastructure, coupled with high healthcare expenditure that supports the rapid adoption of new technologies. Additionally, the region is also experiencing heightened public awareness and acceptance of new healthcare technologies, driving the demand for non-invasive glucose monitoring solutions. The market share can also be attributed to the supportive government initiatives and reimbursement policies.
The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott Laboratories, established in 1888, is a global healthcare company headquartered in Abbott Park, Illinois, USA. The company specialises in the designing, manufacturing, and marketing of a wide range of medical products, including diagnostics, medical devices, and branded generic pharmaceuticals.
PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to society through healthcare solutions that have a positive impact and improve the lives of people.
Sanofi is a French multinational pharmaceutical and healthcare company focused on developing treatments for diabetes, cardiovascular diseases, rare diseases, multiple sclerosis, and vaccines. The company has major plans to enhance its capabilities in innovative diagnostic solutions.
DexCom, Inc. is a company focused on the development, manufacturing, production, and distribution of continuous glucose monitoring (CGM) systems for diabetes management.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Site Outlook |
|
Breakup by Application |
|
Breakup by End-User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share